| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/11/1987 | US4685883 Biodegradable microsperes inserted in gums |
| 08/05/1987 | EP0231091A1 Stable emulsions of highly fluorinated organic compound |
| 08/05/1987 | EP0231070A2 Fluorocarbon blood substitutes |
| 08/05/1987 | EP0231040A1 Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension |
| 08/05/1987 | EP0231039A1 Process for preparing immunological complexes and pharmaceutical composition containing these complexes |
| 08/05/1987 | EP0231026A1 Sustained-release dihydropyridine formulation |
| 08/05/1987 | EP0230932A2 Method for production of stable nicorandil preparation |
| 08/05/1987 | EP0230881A2 Pharmaceutical preparations containing ciprofloxacin |
| 08/05/1987 | EP0230654A2 Sustained pulsewise release pharmaceutical preparation |
| 08/05/1987 | EP0230647A2 Method for producing a sustained release formulation |
| 08/05/1987 | EP0179092A4 Solutions of mitomycin. |
| 08/04/1987 | US4684698 Water soluble multicomplex of chlorothiazide, furosemide and poly(N-vinyl-2-pyrrolidone) |
| 08/04/1987 | US4684666 Ibuprofen syrup |
| 08/04/1987 | US4684643 Pharmaceutical compositions for storage in plastic containers and process therefor |
| 08/04/1987 | US4684638 Metal complexes of bis-indole compounds and aqueous pharmaceutical compositions containing them |
| 08/04/1987 | US4684633 Phospholipid-emulsified prostaglandin composition |
| 08/04/1987 | US4684632 Formulation with special 1,2-diacylglycero-3-phosphocholines for the treatment of gastrointestinal disorders |
| 08/04/1987 | US4684534 Carbohydrate binder |
| 08/04/1987 | US4684528 Flavor of zinc supplements for oral use |
| 08/04/1987 | US4684524 Rate controlled dispenser for administering beneficial agent |
| 08/04/1987 | US4684523 Shell of sorbitol and aspartame |
| 08/04/1987 | US4684516 Sustained release tablets and method of making same |
| 08/04/1987 | CA1225033A1 Opthalmic anti-inflammatory agents |
| 08/04/1987 | CA1225032A1 Injectable therapeutic compositions containing stable s-adenosyl-l-methionine salts |
| 08/04/1987 | CA1225030A1 Crosslinked, porous polymers for controlled drug delivery |
| 08/04/1987 | CA1225029A1 Medicaments with a high degree of solubility and method for their production |
| 08/04/1987 | CA1225028A1 Controlled release tablet |
| 08/04/1987 | CA1225027A1 Sensitization of hypoxic tumor cells and control of growth thereof |
| 07/30/1987 | WO1987004367A1 Covalent membranes |
| 07/30/1987 | WO1987004350A1 Process for improving the adherence of gels to mucous membranes |
| 07/30/1987 | WO1987004347A1 Solubilization of hydrophobic materials using lysophospholipid |
| 07/30/1987 | WO1987004345A1 Topical antiinflammatory compositions |
| 07/30/1987 | WO1987004343A1 Sustained-release preparation |
| 07/30/1987 | WO1987004342A1 Buccal formulation |
| 07/30/1987 | WO1987003490A3 Transdermal delivery system |
| 07/30/1987 | DE3602434A1 Use of solid fatty acid glycerides as aids for reducing particle size and the use of size-reduced products for pharmaceutical formulations |
| 07/29/1987 | EP0230332A1 A pharmaceutical composition with sustained release of the active component and a process for the preparation thereof |
| 07/29/1987 | EP0230298A2 Stable solid preparation of thiol or thiol ester derivatives |
| 07/29/1987 | EP0230294A2 Drug applicator |
| 07/29/1987 | EP0230264A2 Pharmaceutical composition for nasal application, process for its preparation and its use |
| 07/29/1987 | EP0230226A2 Antimycotic emulsions |
| 07/29/1987 | EP0229844A1 Fat emulsion of prostaglandin i 2? |
| 07/28/1987 | US4683288 Lactic acid and glycolic acid polymers |
| 07/28/1987 | US4683256 Dry edible film coating composition, method and coating form |
| 07/28/1987 | US4683242 Transdermal treatment for pain and inflammation with 2-amino-3-aroylbenzeneacetic acids, salts and esters |
| 07/28/1987 | US4683131 Divisible pharmaceutical tablet with delayed active ingredient release |
| 07/28/1987 | US4683092 Capsule loading technique |
| 07/23/1987 | DE3700911A1 Drug delivery system |
| 07/22/1987 | EP0229594A2 Polyvinylprolidone-containing coating for comestibles |
| 07/22/1987 | EP0229561A1 Dermatological, pharmaceutical or cosmetic composition consisting of hydrated lipid lamellar phases or liposomes and containing retinoids or analogues such as carotenoids |
| 07/22/1987 | EP0229400A2 Fatty acids modified polyesters, process for their preparation, and their use for the increase of viscosity in compositions containing tensides |
| 07/22/1987 | EP0229398A2 Capsules, and method and apparatus for producing such capsules |
| 07/22/1987 | EP0229375A1 Oral hygiene composition |
| 07/22/1987 | EP0116085B1 Interferon and interferon inducers combined with tobacco products |
| 07/21/1987 | US4681876 Antifungal utility of bile acids |
| 07/21/1987 | US4681766 Sugar and sugarless coatings |
| 07/21/1987 | US4681765 Rapid releasing triamterene containing gelatin capsule dosage forms for once daily antihypertensive use |
| 07/21/1987 | US4681759 Polyvinylpyrrolidone, antiulcer |
| 07/21/1987 | US4681756 Administering vitamins c and e as blocking agents in the stomach |
| 07/21/1987 | US4681755 Delivery device for zero-order release of an active principle into a dissolution fluid and process for its preparation |
| 07/21/1987 | US4681752 Capsules containing the active principle of an allergen, and process for their preparation |
| 07/21/1987 | US4681635 Topical collodion compositions |
| 07/21/1987 | US4681584 Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes |
| 07/21/1987 | US4681583 System for dispersing drug in biological environment |
| 07/21/1987 | US4681582 Liposome entrapping drug, fluid flow |
| 07/21/1987 | CA1224418A1 Therapeutic compositions for oral use containing stable s-adenosyl-l-methionine salts |
| 07/21/1987 | CA1224417A1 Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range |
| 07/16/1987 | WO1987004184A1 Process for granulating enzyme |
| 07/16/1987 | WO1987004077A1 Gastro-oesophageal reflux composition |
| 07/16/1987 | WO1987004070A1 Aqueous dispersions of waxes and lipids for pharmaceutical coating |
| 07/16/1987 | WO1987004069A1 Antitoxin vaginal products and catamenials comprising ascorbic acid |
| 07/15/1987 | EP0229000A2 Encapsulation composition for use with chewing gum and edible products |
| 07/15/1987 | EP0228999A2 Coatings for chewing gums containing gum arabic and a soluble calcium salt |
| 07/15/1987 | EP0228862A2 Stabilized human tissue plasminogen activator compositions |
| 07/15/1987 | EP0228692A2 skin marker |
| 07/15/1987 | EP0228485A1 Aqueous pigment suspension |
| 07/14/1987 | US4680323 Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration |
| 07/14/1987 | US4680312 Stable prostaglandin E gels utilizing colloidal silicon dioxide as a gel-forming agent |
| 07/14/1987 | US4680175 Interferon administration vehicles |
| 07/14/1987 | US4680172 Arecoline and derivatives |
| 07/14/1987 | US4680171 Visualization of a bloodstream circulation with biodegradable microspheres |
| 07/14/1987 | CA1224150A1 Stable water-in-oil emulsions containing polyoxyalkylene block copolymers |
| 07/14/1987 | CA1224149A1 Clear analgesic gels with reduced tackiness |
| 07/14/1987 | CA1224148A1 Drug delivery system utilizing thermosetting gels |
| 07/14/1987 | CA1224147A1 Betamethasone dipropionate cream |
| 07/14/1987 | CA1224143A1 Increasing the enteral absorbability of heparin or heparinoids, and the heparin or heparinoid preparation thus obtainable |
| 07/14/1987 | CA1224142A1 Transfer factor composition and skin treatment |
| 07/08/1987 | EP0228239A2 Preparation of a medicament for arthritis and rheumatism |
| 07/08/1987 | EP0228164A2 Effervescent composition containing ibuprofen |
| 07/08/1987 | EP0228067A2 Seamless soft capsule |
| 07/08/1987 | EP0227988A2 Therapeutic system |
| 07/08/1987 | EP0227955A2 Composite wound dressing |
| 07/08/1987 | EP0227836A1 Sustained releasing patch |
| 07/08/1987 | EP0227816A1 Transdermal verapamil delivery device |
| 07/08/1987 | EP0227814A1 Therapeutic formulations with bimodal release characteristics |
| 07/08/1987 | EP0227656A1 Pharmaceutical compositions containing gels |
| 07/08/1987 | CN86108096A Stabilized benzimidazole derivatives |
| 07/07/1987 | US4678814 Fluorescent and amgnetized derivative copolymers, medical applications |
| 07/07/1987 | US4678812 Trehalose as stabilizer and tableting excipient |
| 07/07/1987 | US4678809 Injectable fomulations of disulfiram for the treatment of alcoholism |